Liou JP - Search Results

1

Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors.

Liou JP, Wu ZY, Kuo CC, Chang CY, Lu PY, Chen CM, Hsieh HP, Chang JY. Liou JP, et al. J Med Chem. 2008 Jul 24;51(14):4351-5. doi: 10.1021/jm800150d. Epub 2008 Jun 28. J Med Chem. 2008. PMID: 18588280

2

C-alkylated spiro[benzofuran-3(2H),4'-1'-methyl-piperidine-7-ols] as potent opioids: a conformation-activity study.

Tsai YC, Liou JP, Liao R, Cheng CY, Tao PL. Tsai YC, et al. Among authors: liou jp. Bioorg Med Chem Lett. 1998 Jul 21;8(14):1813-8. doi: 10.1016/s0960-894x(98)00318-7. Bioorg Med Chem Lett. 1998. PMID: 9873439

3

Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.

Liou JP, Chang CW, Song JS, Yang YN, Yeh CF, Tseng HY, Lo YK, Chang YL, Chang CM, Hsieh HP. Liou JP, et al. J Med Chem. 2002 Jun 6;45(12):2556-62. doi: 10.1021/jm010365+. J Med Chem. 2002. PMID: 12036364

4

Structure-activity and crystallographic analysis of benzophenone derivatives-the potential anticancer agents.

Hsieh HP, Liou JP, Lin YT, Mahindroo N, Chang JY, Yang YN, Chern SS, Tan UK, Chang CW, Chen TW, Lin CH, Chang YY, Wang CC. Hsieh HP, et al. Among authors: liou jp. Bioorg Med Chem Lett. 2003 Jan 6;13(1):101-5. doi: 10.1016/s0960-894x(02)00850-8. Bioorg Med Chem Lett. 2003. PMID: 12467626

5

Dual inhibition of topoisomerase I and tubulin polymerization by BPR0Y007, a novel cytotoxic agent.

Chang JY, Hsieh HP, Pan WY, Liou JP, Bey SJ, Chen LT, Liu JF, Song JS. Chang JY, et al. Among authors: liou jp. Biochem Pharmacol. 2003 Jun 15;65(12):2009-19. doi: 10.1016/s0006-2952(03)00197-7. Biochem Pharmacol. 2003. PMID: 12787881

6

Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.

Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP. Liou JP, et al. J Med Chem. 2004 May 20;47(11):2897-905. doi: 10.1021/jm0305974. J Med Chem. 2004. PMID: 15139768

7

A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.

Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY. Juang SH, et al. Among authors: liou jp. Biochem Pharmacol. 2004 Jul 15;68(2):293-303. doi: 10.1016/j.bcp.2004.03.036. Biochem Pharmacol. 2004. PMID: 15194001

8

BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.

Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY. Kuo CC, et al. Among authors: liou jp. Cancer Res. 2004 Jul 1;64(13):4621-8. doi: 10.1158/0008-5472.CAN-03-3474. Cancer Res. 2004. PMID: 15231674

9

Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.

Liou JP, Chang YL, Kuo FM, Chang CW, Tseng HY, Wang CC, Yang YN, Chang JY, Lee SJ, Hsieh HP. Liou JP, et al. J Med Chem. 2004 Aug 12;47(17):4247-57. doi: 10.1021/jm049802l. J Med Chem. 2004. PMID: 15293996

10

Pharmaceutical design of antimitotic agents based on combretastatins.

Hsieh HP, Liou JP, Mahindroo N. Hsieh HP, et al. Among authors: liou jp. Curr Pharm Des. 2005;11(13):1655-77. doi: 10.2174/1381612053764751. Curr Pharm Des. 2005. PMID: 15892667 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters